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Abstract 
Background: Plants have been among us for millions of years and about 70% of the world’s 
population utilizes plants for healing purposes. Artostaphylos uva-ursi is one of the most 
commonly used plant in the treatment of urinary tracts infections as it possesses great 
antimicrobial properties, 
Material and Methods: Herbal extract and homeopathic mother tincture of Arctostaphylos uva-
ursi was investigated for its antimicrobial activity against selected microorganisms (Aspergillus 
Species, Candida albicans and Escherichia coli). These microorganisms are among the most 
pathogenic microorganisms on earth, they can cause diseases in immunocompromised patients. 
The method used was the Kirby-Bauer disc diffusion susceptibility test method. 
Results: The herbal extract and the homeopathic mother tincture of Arctostaphylos uva-ursi 
showed antimicrobial activity against both Candida albicans and Escherichia coli but it did 
not show any activity against the selected Aspergillus Species (A. flavus, A. fumigatus and A. 
niger). 
Conclusion: The herbal extract showed greater antimicrobial property than the homeopathic 
mother tincture. The result is not conclusive because we did not determine and isolate the active 
ingredients in starting material, therefore further research should be done in that regard. 
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Introduction 
Antimicrobial resistance has become an increasing problem in the treatment of infections 
caused by bacteria, parasites, viruses and fungi. Treatment of patients has become challenging, 
costly or even impossible given the decrease in the efficacy of antibacterial, antiparasitic, 
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antiviral and antifungal drugs (Dyner, 2009). The development of antimicrobial resistance is a 
naturally occurring process in microorganisms; however, this process is accelerated when 
antimicrobial agents are inadequately administered to humans and/or animals (Kinge, et al., 
2010). 
There are about 100 trillion microorganisms living in the human body as well as other animals. 
Most of these microorganisms are helpful while others can be harmful. Aspergillus species, 
Candida albicans (C. albicans) and Escherichia coli (E. coli) are among the most pathogenic 
microorganisms on earth. These pathogens can cause diseases in immunocompromised patients 
(Kabir, et al., 2012). 
Aspergillus species are primarily opportunistic pathogens as well as allergens. They are very 
dangerous bacteria moulds, capable of causing blood and pulmonary infections in both humans 
and animals (Maertens, et al., 2017).C. albicans is one of the most important opportunistic 
pathogens, even though it is present in the human normal flora (Matthaiou, et al., 2015). It can 
cause infections when the host becomes debilitated or immunocompromised. At least 75% of 
women will get a Candida infection in their lifetime (Kabir, et al., 2012). Antifungal drugs 
such as Azoles, which are the main form of treatment for Candida infections, are becoming 
less effective as Candida is developing resistance against these drugs (Spampinato & Leonardi, 
2013). E. coli is the bacteria causing the most infections in humans and animals. Research has 
shown that Shiga toxin-producing E. coli causes more than 265000 illnesses a year in the 
United States alone. Recent statistics have shown that about 90% of all community acquired 
urinary tract infections (UTIs) are caused by Uropathogenic E. coli (Santo, et al., 2007). UTIs 
are one of the most common bacterial infections in humans, they affect about 50%-60% of 
adult females. UTIs are the second motive for antibiotic prescription, usage and resistance 
(Ranjbarian, 2007). E. coli multi-drug resistance against β lactam groups (Penicillin, 
Cephalosporins, Carbapenems and Monobactams) is on the rise (Manges, et al., 2010). These 
bacteria can obtain resistance genes from other microorganisms and then spread them to other 
pathogens (Polse, et al., 2016). 
There is an increased need to replace antimicrobial agents that have become ineffective (World 
Health Organization, 2014). Plants have been among us for millions of years and about 70% 
of the world’s population utilizes plants for health purposes, therefore the way forward might 
be to utilise plants as alternative means of treatment (Mamedov, 2012). 
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Material and methods 
This investigation was undertaken by individually preparing fresh fungal spores of Aspergillus 
species and C. albicans as well as cells of E. coli adjusted to McFarland standards of 0.5. C. 
albicans, E. coli and the three different Aspergillus species were tested against the herbal 
extract and the mother tincture of Arctostaphylos uva-ursi on distinct agar plates prepared 
beforehand. The individual plates labelled with the organisms’ name and the extracts to be 
tested were then streaked with the respective organisms using sterile swabs and allowed to dry 
at room temperature for about 5 minutes. Furthermore, the discs impregnated with about 20µL 
of different concentrations of the herbal extract or the mother tincture of the plant were 
individually placed on the agar surface of the streaked plates using sterile forceps. Antibiotics 
were used as positive controls, namely Amphotericin B for plates streaked with Aspergillus 
species, Clotrimazole for plates streaked with C. albicans and Neomycin for plates streaked 
with E. coli. Ethanol was used as negative control for all the plates, with a dosage of either 
30% in the case of the herbal extract or 46% in the case of the mother tincture. The plates were 
then inverted and incubated at a temperature of 35˚C for 48 hours except the plates streaked 
with E. coli which were incubated at a temperature of 35˚C for 16 hours. Finally, the zones of 
inhibition around each of the impregnated discs were measured and the results were recorded 
in millimetres. These experiments were done in triplicate and was repeated twice on separate 
days to ensure reproducibility and accuracy 
Data Analysis 
The statistician made use of the ANOVA method to statistically analyse the data collected. 
According to Goldstein, (2015), ANOVA (Analysis of variance) refers to an analysis of a 
continuous dependent variable where all predictor variables are categorical. Two-way ANOVA 
refers to two predictors, and if the two are allowed to interact in the model, two-way ANOVA 
involves cross-classification of observations simultaneously by both factors. 
Results and discussion 
Table 1: Mean zones of inhibition of the HE on A. flavus in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
HE discs 1 0.0 0.0 0.0 
HE discs 2 0.0 0.0 0.0 
HE discs 3 0.0 0.0 0.0 
Ethanol 30% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 25.0 22.0 28.0 
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Figure 1: A. flavus streaked plates, with HE discs of various concentrations. 
 
Table 2: Mean zones of inhibition of the MT on A. flavus in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
MT discs 1 0.0 0.0 0.0 
MT discs 2 0.0 0.0 0.0 
MT discs 3 0.0 0.0 0.0 
Ethanol 46% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 22.0 22.0 24.0 
 
 
Figure 2: A. flavus streaked plates, with MT discs of various concentrations. 
Table 3: Mean zones of inhibition of the HE on A. fumigatus in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
HE discs 1 0.0 0.0 0.0 
HE discs 2 0.0 0.0 0.0 
HE discs 3 0.0 0.0 0.0 
Ethanol 30% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 12.0 12.0 15.0 
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Figure.3: A. fumigatus streaked plates, with HE discs of various concentrations. 
 
Table 4: Mean zones of inhibition of the MT on A. fumigatus in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
MT discs 1 0.0 0.0 0.0 
MT discs 2 0.0 0.0 0.0 
MT discs 3 0.0 0.0 0.0 
Ethanol 46% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 13.0 13.0 14.0 
 
 
Figure 4: A. fumigatus streaked plates, with MT discs of various concentrations. 
Table 5: Mean zones of inhibition of the HE on A. niger in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
HE discs 1 0.0 0.0 0.0 
HE discs 2 0.0 0.0 0.0 
HE discs 3 0.0 0.0 0.0 
Ethanol 30% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 15.0 15.0 16.0 
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Figure 5: A. niger streaked plates, with HE discs of various concentrations. 
Table 6: Mean zones of inhibition of the MT on A. niger in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
MT discs 1 0.0 0.0 0.0 
MT discs 2 0.0 0.0 0.0 
MT discs 3 0.0 0.0 0.0 
Ethanol 46% discs 4 0.0 0.0 0.0 
Amphotericin B discs 5 13.0 13.0 14.0 
 
 
Figure 6: A. niger streaked plates, with MT discs of various concentrations. 
Table 7: Mean zones of inhibition of the HE on C. albicans in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
HE discs 1 25.0 26.0 25.0 
HE discs 2 15.0 15.0 15.0 
HE discs 3 0.0 0.0 0.0 
HE discs 4 0.0 0.0 0.0 
Ethanol 30% discs 5 0.0 0.0 0.0 
Clotrimazole discs 6 17.0 17.0 17.0 
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Figure 7: C. albicans streaked plates, with HE discs of various concentrations. 
 
Table 8: Mean zones of inhibition of the MT on C. albicans in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
MT discs 1 21.0 20.0 21.0 
MT discs 2 11.0 11.0 11.0 
MT discs 3 0.0 0.0 0.0 
MT discs 4 0.0 0.0 0.0 
Ethanol 46% discs 5 0.0 0.0 0.0 
Clotrimazole discs 6 18.0 18.0 18.0 
 
 
Figure 8: C. albicans streaked plates, with MT discs of various concentrations. 
Table 9: Mean zones of inhibition of the HE on E. coli in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
HE discs 1 14.0 14.0 12.0 
HE discs 2 8.0 9.0 10.0 
HE discs 3 7.0 7.0 7.0 
HE discs 4 0.0 0.0 0.0 
Ethanol 30% discs 5 0.0 0.0 0.0 
Neomycin discs 6 27.0 27.0 27.0 
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Figure 9: E. coli streaked plates, with HE discs of various concentrations. 
 
Table 10: Mean zones of inhibition of the MT on E. coli in millimetres. 
DISCS 
PLATES 
No. 1 No. 2 No. 3 
MT discs 1 8.0 8.0 8.0 
MT discs 2 8.0 8.0 9.0 
MT discs 3 7.0 7.0 8.0 
MT discs 4 0.0 0.0 0.0 
Ethanol 46% discs 5 0.0 0.0 0.0 
Neomycin discs 6 27.0 28.0 29.0 
 
 
Figure 10: E. coli streaked plates, with MT discs of various concentrations. 
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Conclusion 
The herbal extract and the homeopathic mother tincture of Arctostaphylos uva-ursi were both 
able to show antimicrobial properties against Candida albicans and Escherichia coli however 
they did not show any activity against Aspergillus species. The herbal extract showed greater 
antimicrobial activity than the homeopathic mother tincture however the results are not 
conclusive as there were few limitations to the study. The limitation we encountered was that 
there was no similar research done in the past, the plant active ingredient was not isolated, and 
the different extract were obtained from different sources hence we could not determine the 
starting concentration. This limitation can open a window for someone to further research. 
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